Metabolic-Syndrome-Related Comorbidities in Narcolepsy Spectrum Disorders: A Preliminary Cross-Sectional Study in Japan

資料種別:
論文(リポジトリ)
責任表示:
Futenma, Kunihiro ; Takaesu, Yoshikazu ; Nakamura, Masaki ; Hayashida, Kenichi ; Takeuchi, Noboru ; Inoue, Yuichi
言語:
英語
出版情報:
MDPI, 2022-05-22
著者名:
Futenma, Kunihiro
Takaesu, Yoshikazu
Nakamura, Masaki
Hayashida, Kenichi
Takeuchi, Noboru
Inoue, Yuichi
続きを見る
掲載情報:
International Journal of Environmental Research and Public Health
巻:
19
通号:
10
バージョン:
VoR
概要:
Narcolepsy types 1 (NT1) and 2 (NT2) and idiopathic hypersomnia (IH) are thought to be a disease continuum known as narcolepsy spectrum disorders (NSDs). This study aimed to assess the prevalence of and factors associated with metabolic-syndrome-related disorders (MRDs) among patients with NSD. Japanese patients with NSD (NT1, n = 94; NT2, n = 83; and IH, n = 57) aged ≥35 years were enrolled in this cross-sectional study. MRD was defined as having at least one of the following conditions: hypertension, diabetes, or dyslipidemia. Demographic variables and MRD incidence were compared among patients in the respective NSD categories. Multivariate logistic regression analysis was used to investigate the factors associated with MRDs. Patients with NT1 had a higher body mass index (BMI) and incidence of MRD than that had by those with NT2 or IH. Age, BMI, and the presence of OSA were significantly associated with the incidence of MRD in NSDs. Age and BMI in NT1, BMI and human leukocyte antigen (HLA)-DQB1*06:02 positivity in NT2, and only age in IH were factors associated with the incidence of MRD. Obesity should be carefully monitored in narcolepsy; however, NT2 with HLA-DQB1*06:02 positive should be followed up for the development of MRD even without obesity. 続きを見る
URL:
http://hdl.handle.net/20.500.12000/0002019345
電子版
Loading